These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 16135133

  • 1. Unlocking the opportunity of tight glycaemic control. Far from goal.
    Del Prato S.
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133
    [Abstract] [Full Text] [Related]

  • 2. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy.
    Scherbaum WA.
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137
    [Abstract] [Full Text] [Related]

  • 3. Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung.
    Patton JS.
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S5-8. PubMed ID: 16135136
    [Abstract] [Full Text] [Related]

  • 4. Unlocking the opportunity of tight glycaemic control. Promise ahead: the role of inhaled insulin in clinical practice.
    Heine RJ.
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S19-23. PubMed ID: 16135135
    [Abstract] [Full Text] [Related]

  • 5. An update on the long-acting insulin analogue glargine.
    Thisted H, Johnsen SP, Rungby J.
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [Abstract] [Full Text] [Related]

  • 6. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
    Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
    [Abstract] [Full Text] [Related]

  • 7. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N, Riveline JP, Tubiana-Rufi N, Vambergue A, Catargi B, Melki V, Charpentier G, Guerci B.
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [Abstract] [Full Text] [Related]

  • 8. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA.
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [Abstract] [Full Text] [Related]

  • 9. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 10. [Management of children and adolescents with diabetes mellitus: personal experience].
    Dorchy H.
    Rev Med Brux; 2005 Sep; 26(4):S246-54. PubMed ID: 16240870
    [Abstract] [Full Text] [Related]

  • 11. Type 1 diabetes: benefits of intensive insulin therapy. Patients should control blood glucose strictly.
    Prescrire Int; 2002 Apr; 11(58):61. PubMed ID: 11987320
    [Abstract] [Full Text] [Related]

  • 12. [Biotechnological and administration innovations in insulin therapy].
    Verge D.
    Med Sci (Paris); 2004 Nov; 20(11):986-98. PubMed ID: 15525494
    [Abstract] [Full Text] [Related]

  • 13. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.
    Klonoff DC.
    Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014
    [Abstract] [Full Text] [Related]

  • 14. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW.
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [Abstract] [Full Text] [Related]

  • 15. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW.
    Clin Ther; 2007 Jul; 29 Suppl D():S135-44. PubMed ID: 18191065
    [Abstract] [Full Text] [Related]

  • 16. [Trust is good, control is better. Glucose tests, insulin syringes, needles].
    Fink E.
    Pharm Unserer Zeit; 2001 Jan; 30(1):34-9. PubMed ID: 11233181
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.